Shuttle Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $9 | $0 | $9 | $0 |
Gross Profit | -1 | 7 | -1 | |
EBITDA | -1,481 | -1,382 | -1,280 | -1,576 |
EBIT | -1,482 | -1,384 | -1,282 | -1,578 |
Net Income | -2,031 | -1,731 | -1,640 | -1,792 |
Net Change In Cash | 9 | 0 | 9 | 0 |
Free Cash Flow | -1,399 | -1,239 | -1,043 | -1,553 |
Cash | 695 | 1,398 | 2,576 | 3,885 |
Basic Shares | 16,572 | 16,572 | 16,069 | 15,744 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -66 | -60 | -54 |
EBITDA | -5,885 | -2,158 | -1,682 | -454 |
EBIT | -5,892 | -2,164 | -1,742 | -509 |
Net Income | -6,592 | -3,099 | -1,202 | -845 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,600 | -2,710 | -300 | -37 |
Cash | 2,576 | 8,417 | 504 | 117 |
Basic Shares | 1,864 | 10,351 | 13,586 | 13,586 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.96 |
2024-03-31 | -$0.83 |
2023-12-31 | -$0.81 |
2023-09-30 | -$0.91 |
